Analytica Stock

Analytica P/B

Delisted

The P/B (Price-to-Book Ratio) of Analytica (ALT.AX) as of Aug 6, 2026 is -31.42. In the previous year, P/B (Price-to-Book Ratio) was 2.20 — a change of -1,525.90% (lower).

P/B

-31.42

YoY

-1,525.90%

Last updated:

P/B (Price-to-Book Ratio) of Analytica is 2026 -31.42 . P/B (Price-to-Book Ratio) of Analytica was 2025 2.20 . It decreases by -1,525.90% lower compared to the previous year.
Access this data via the Eulerpool API

Analytica Stock analysis

What does Analytica do? Analytica Ltd is a British company that was founded in 1970 by Dr. John Smith. Originally, it specialized in the development of analysis instruments for the chemistry and life sciences, particularly liquid chromatography. Over the years, the company expanded its offerings and now provides a wide range of products and services. Analytica Ltd has become a global company with a presence in over 130 countries. It operates in various business areas, including analytical chemistry, bioanalysis, environmental and food analysis, and clinical diagnostics. The company offers customers a wide range of products, such as chromatography systems, mass spectrometers, specialized analysis devices, and consumables. It has also specialized in the development and manufacturing of medical devices, including diagnostic tools for conditions such as diabetes, cholesterol, and other metabolic diseases. Analytica Ltd incorporates innovative technologies like miniaturization and nanotechnology into its products. In addition to product sales, Analytica Ltd provides tailored services. The company has highly qualified experts who assist customers with method development, process optimization, and data interpretation. It also conducts research and development programs to continuously develop new products and technologies. Analytica Ltd maintains numerous collaborations and partnerships with other companies and organizations. For example, it works closely with research institutions and universities to develop new technologies and products. The company also connects with other companies in the health and analytical industries to share innovations and best practices. Overall, Analytica Ltd is a leading provider of analysis solutions for the pharmaceutical, biotech, chemical, and food industries, as well as research institutions and clinical laboratories. The company is continuously working to further develop its products and services to meet the needs of its customers and address the ever-changing challenges of the industry. Analytica is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Analytica stock

P/B (Price-to-Book Ratio) of Analytica is -31.42 in 2026.

P/B (Price-to-Book Ratio) of Analytica changed from 2.20 to -31.42, representing a -1,525.90% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of P/B (Price-to-Book Ratio) Analytica since 2006 – with annual values, charts, and detailed analysis.

The Price-to-Book ratio compares a company's market price to its book value. A low P/B may indicate an undervalued stock, while a high P/B could suggest overvaluation or strong growth expectations.

P/B = Stock Price / Book Value per Share

To evaluate P/B (Price-to-Book Ratio)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for P/B (Price-to-Book Ratio).

A 'good' varies by industry and company stage. On Eulerpool, you can compare P/B (Price-to-Book Ratio)'s Analytica with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

Valuation — Analytica

All Key Metrics — Analytica